AI assistant
Sending…
TENAX THERAPEUTICS, INC. — Director's Dealing 2021
Jul 9, 2021
34835_dirs_2021-07-08_9667121f-091d-4885-aac2-6224f249ffda.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TENAX THERAPEUTICS, INC. (TENX)
CIK: 0000034956
Period of Report: 2021-07-06
Reporting Person: DiTonno Anthony A (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-07-06 | Stock Option (right to buy) | $1.97 | A | 50000 | Acquired | 2031-07-06 | Common Stock (50000) | Direct |
More from TENAX THERAPEUTICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Share Issue/Capital Change
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
May 9
Major Shareholding Notification
2026
May 7
Major Shareholding Notification
2026
May 7
Major Shareholding Notification
2026
May 4
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22